EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments

Dennis A Steindler iD, Katherine Karakoula iD

Cells · 26.04.2026 · 15 (9) · 783

DOI: 10.3390/cells15090783 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 26.04.2026. Verfasst von Dennis A Steindler und 1 weiteren Autor:innen. Beteiligte Einrichtung: Steindler Consulting, Boston, MA, USA. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Immunotherapy, Molecular Targeted Therapy. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advances in organoid and other three-dimensional culture systems, single-cell and spatial transcriptomics, multi-omics, and high-resolution imaging are reshaping our understanding of the cellular origins and evolutionary trajectories of glioblastoma. When integrated with modern data science approaches, these technologies enable the construction of increasingly detailed molecular biographies of normal neural stem and progenitor cells as well as malignant stem-like cellular states. Such molecular biographies illuminate how developmental programs, cellular plasticity, and microenvironmental cues are co-opted during gliomagenesis. At the same time, progress in machine learning, immunotherapy, and precision molecular targeting is beginning to translate these biological insights into therapeutic strategies that specifically disrupt glioblastoma stem-like states. Together, these converging approaches provide a conceptual and technological framework for improved tumor modeling, earlier detection, and increasingly personalized therapies for malignant gliomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaImmunotherapyMolecular Targeted TherapyNeoplastic Stem CellsPrecision MedicineAnimalsHumansTumor Microenvironment

Stichwörter der Autor:innen

cancer stem celldata scienceglioblastomagliomamolecular and immunotherapiesneurogenesis

Autor:innen und Institutionen

  • Steindler Consulting, Boston, MA, USA.
  • Round Table Research, Inc., Research Triangle Park, Chapel Hill, NC 27709, USA.
  • The Eshelman Institute for Innovation, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • School of Pharmacy and Life Sciences, Research Institute of Healthcare Sciences, University of Wolverhampton, City Campus, Wolverhampton WV1 1LY, UK.

ORCID-Profile: Dennis A Steindler, Katherine Karakoula

Zitieren

APA

Steindler, D. A., & Karakoula, K. (2026). Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments. Cells, 15(9), 783. https://doi.org/10.3390/cells15090783

Vancouver

Steindler DA, Karakoula K. Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments. Cells. 2026;15(9):783. doi:10.3390/cells15090783

BibTeX
@article{Steindler2026,
  author = {Steindler, Dennis A and Karakoula, Katherine},
  title = {Glioblastoma Stem Cells as Targets for Emerging Precision Immunotherapies and Molecular Treatments},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {9},
  pages = {783},
  doi = {10.3390/cells15090783}
}
Kostenlos starten →